You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plasma PAI-1 level at 0, 4, 8 weeks

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Self-harm Behaviour Among the Most At-risk Adolescents

Not yet recruiting
  • Self-harm
  • +5 more
  • Enrollment questionnaire, General questionnaire1, General questionnaire2, General questionnaire3
  • +12 more
  • Ljubljana, Slovenia
  • +1 more
Mar 13, 2023

The Right Care, for Right Patient, at Right Time, by Right

Not yet recruiting
  • Ambulatory Care
  • +3 more
  • On-site recruitment (information and consent) following a random sampling recruitment schedule
  • +2 more
  • Kingston, Ontario, Canada
  • +6 more
May 26, 2023

Influenza, Human Trial in Gent, Wilrijk (GSK4382276A Dose level 1, GSK4382276A Dose level 2, GSK4382276A Dose level 3)

Active, not recruiting
  • Influenza, Human
  • GSK4382276A Dose level 1
  • +4 more
  • Edegem, Belgium
  • +6 more
Jan 9, 2023

Meningococcal Invasive Infections at Participating Centers

Recruiting
  • Invasive Meningococcal Disease
  • surveillance
  • Calgary, Alberta, Canada
  • +12 more
Apr 4, 2022

COVID-19 Trial in Brazil, Canada, United States (Convalescent plasma)

Terminated
Has Results
  • COVID-19
  • Convalescent plasma
  • Brooklyn, New York
  • +72 more
Mar 1, 2022

Neonatal Encephalopathy, Newborn Asphyxia Trial in United Kingdom (procedure, other, diagnostic test)

Not yet recruiting
  • Neonatal Encephalopathy
  • Newborn Asphyxia
  • Whole body hypothermia
  • +3 more
  • Ashford, United Kingdom
  • +18 more
May 25, 2023

HIV Trial in Badalona (DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM), At least 24 weeks since

Completed
  • HIV
  • DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM)
  • +2 more
  • Badalona, Barcelona, Spain
    IrsiCaixa AIDS Research Institute, Hospital Universitari Germans
Apr 7, 2021

HIV Infection Trial in Badalona (ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).,

Recruiting
  • HIV Infection
  • ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).
  • Normal saline solution
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol Hospital
Jul 11, 2022

Enteral Nutrition Trial in Calgary (Early exclusive enteral nutrition)

Recruiting
  • Enteral Nutrition
  • Early exclusive enteral nutrition
  • Calgary, Alberta, Canada
  • +2 more
Dec 19, 2021

Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)

Recruiting
  • Prostate Cancer Metastatic
  • Ablative Radiation Therapy
  • Standard of care
  • Victoria, British Columbia, Canada
  • +14 more
Nov 14, 2022

Local Recurrence Following Breast Conserving Surgery and

Active, not recruiting
  • Breast Cancer
    • Calgary, Alberta, Canada
    • +26 more
    Sep 19, 2022

    Atopic Dermatitis, Plaque Psoriasis Trial (PF-07038124 ointment 0.01%, Vehicle ointment, PF-07038124 ointment 0.03%)

    Recruiting
    • Atopic Dermatitis
    • Plaque Psoriasis
    • PF-07038124 ointment 0.01%
    • +3 more
    • Encinitas, California
    • +31 more
    Jan 23, 2023

    Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia

    Recruiting
    • Myelodysplastic Syndrome
    • +2 more
    • Navitoclax
    • +6 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Feb 2, 2023

    Dental Caries Trial in Puerto Rico, United States (0.24% Sodium Fluoride Dentifrice, 1.5% Arginine Dentifrice, 4.0% Arginine

    Recruiting
    • Dental Caries
    • 0.24% Sodium Fluoride Dentifrice
    • +3 more
    • Loma Linda, California
    • +8 more
    Sep 21, 2022

    Fabry Disease Trial in Worldwide (Pegunigalsidase alfa)

    Completed
    • Fabry Disease
    • Pegunigalsidase alfa
    • Birmingham, Alabama
    • +20 more
    Mar 29, 2022

    Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)

    Active, not recruiting
    • Oropharyngeal Cancer
    • Prince George, British Columbia, Canada
    • +13 more
    Dec 12, 2022

    Pancreatic Adenocarcinoma Trial in Canada (Gemcitabine, Nab-paclitaxel, Durvalumab)

    Active, not recruiting
    Has Results
    • Pancreatic Adenocarcinoma
    • Calgary, Alberta, Canada
    • +26 more
    May 9, 2022

    Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)

    Recruiting
    • Breast Cancer
    • Bowral, New South Wales, Australia
    • +37 more
    Aug 8, 2022

    Obesity Trial in Worldwide (Semaglutide 2.4 mg, Placebo)

    Active, not recruiting
    • Obesity
    • Semaglutide 2.4 mg
    • Placebo
    • Calgary, Alberta, Canada
    • +21 more
    Mar 22, 2022

    Erosive Esophagitis Trial in Worldwide (X842, X842 Dummy, Lansoprazole)

    Recruiting
    • Erosive Esophagitis
    • DeBary, Florida
    • +66 more
    Jun 10, 2022

    Lung Cancer Metastatic Trial in Australia, Canada (Durvalumab, Tremelimumab, Platinum-Based Drug)

    Active, not recruiting
    Has Results
    • Lung Cancer Metastatic
    • Campbelltown, New South Wales, Australia
    • +48 more
    Jun 23, 2022

    Osteogenesis Imperfecta (OI) Trial in Worldwide (Denosumab, No treatment, Alternative osteoporosis medications)

    Terminated
    Has Results
    • Osteogenesis Imperfecta (OI)
    • Los Angeles, California
    • +21 more
    Nov 28, 2022

    Prostate Cancer Trial in Canada (Durvalumab, Tremelimumab)

    Active, not recruiting
    • Prostate Cancer
    • Kelowna, British Columbia, Canada
    • +10 more
    Mar 14, 2022

    Advanced Rare Tumours Trial in Canada (Sunitinib, Temsirolimus)

    Active, not recruiting
    • Advanced Rare Tumours
    • Calgary, Alberta, Canada
    • +16 more
    Mar 17, 2022

    Psoriasis Trial in Canada, United States (Apremilast, Placebo)

    Completed
    Has Results
    • Psoriasis
    • Birmingham, Alabama
    • +63 more
    Jan 9, 2023